Pathology Doctors in Waco, TX Accepting Medicare

7 Pathology doctors found. Showing 1 - 7

Dr. Edwin Bigger Morrison, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 3000 Herring, Waco, TX 76708 Phone: 254-202-8753    Fax: 254-202-5675

Daniel Augustus Smith, D.O. Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 601 W Hwy 6, Suite 111, Waco, TX 76710 Phone: 254-752-9621    Fax: 254-752-8378

Cary Daniel Chisholm, M.D. Pathology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 601 W Hwy 6, Suite 111, Waco, TX 76710 Phone: 254-752-9621    Fax: 254-756-2047

Dr. Christopher Noel Thompson, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Pathology Department, Waco, TX 76712 Phone: 254-202-4816

Adam Stephen Johnson, MD, MS Pathology - Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Pathology Department, Waco, TX 76712 Phone: 254-202-4816

Dr. Alan Douglas Northcutt, M.D. Pathology - Dermatopathology Medicare: Not Enrolled in Medicare Practice Location: 100 Hillcrest Medical Blvd, Pathology Dept, Waco, TX 76712 Phone: 254-202-4816    Fax: 254-202-4899

Dr. James Morris Smith, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 3115 Pine Ave, Suite 108, Waco, TX 76708 Phone: 254-752-9621    Fax: 752-752-8378

News Archive

Colorectal cancer screening disparities in certain regions

Individuals from certain areas of the United States are more likely to get screened for colorectal cancer than those from other areas, particularly when comparing non-whites living in different parts of the country. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. Additional research is needed to better understand how colorectal cancer screening disparities develop in some regions and not in others.

FDA approves new treatment for AML patients

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic health conditions or diseases (comorbidities) that may preclude the use of intensive chemotherapy.

Universal Health Care enters into new four-year $40 million senior credit facility

Universal Health Care Group, Inc., a leading managed care organization, today announced that it has entered into a new, four-year, $40 million senior credit facility. The purpose of the borrowings are for the repurchase of shares from a minority private equity shareholder and for general corporate purposes.

New mouse model reveals underlying brain changes linked to autism's social, learning problems

A new mouse model of a genetically-linked type of autism reveals more about the role of genes in the disorder and the underlying brain changes associated with autism's social and learning problems.

Read more Medical News

› Verified 3 days ago